STOCK TITAN

Life360 director Haro exercises 50,000 stock options

The director's reported transactions were effected under a written, pre-established Rule 10b5-1 plan adopted June 9, 2026.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Life360, Inc. director Alex Haro exercised options for 50,000 common shares at $2.53 per share on October 6, 2026. The derivative entry listed 145,565 shares following the transaction. On the same date, he sold 48,608 shares at a weighted average of $41.41 (range $41.137–$42.135) and 1,392 shares at a weighted average of $42.36 (range $42.145–$42.74). The reported transactions were effected pursuant to a written, pre-established Rule 10b5-1 trading plan adopted June 9, 2026.

Insider Haro Alex
Role Director
Sold 50,000 shs ($2.07M)
Approx. gross sale proceeds $2.07M
Approx. exercise cost $126K
Approx. pre-tax spread $1.95M
Type Security Shares Price Value
Exercise Stock Option (right to buy) F1, F5 50,000 $0.00 $0.00
Exercise Common stock F1, F2 50,000 $2.53 $126K
Sale Common stock F1, F3, F2 48,608 $41.41 $2.01M
Sale Common stock F1, F4, F2 1,392 $42.36 $59K
Holdings After Transaction: Stock Option (right to buy) — 145,565 contracts (Direct); Common stock — 1,010,303 shares (Direct)
Footnotes (5)
  1. F1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2. Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.137 to $42.135, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3.
  4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.145 to $42.74, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4.
  5. F5. The stock option is fully vested and exercisable.
Common shares from option exercise 50,000 shares October 6, 2026
Option exercise price $2.53 per share Exercise reported October 6, 2026
Shares listed following option transaction 145,565 shares Derivative entry following the October 6, 2026 transaction
First sale 48,608 shares at a weighted average price of $41.41 per share October 6, 2026; trades ranged from $41.137 to $42.135 per share
Second sale 1,392 shares at a weighted average price of $42.36 per share October 6, 2026; trades ranged from $42.145 to $42.74 per share
Restricted stock units 3,342 restricted stock units Previously granted; each represents a contingent right to receive one common share upon vesting
Rule 10b5-1 trading plan regulatory
"written, pre-established trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
restricted stock units financial
"each of which represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LIF shares did director Alex Haro sell, and at what prices?

On October 6, 2026, Alex Haro sold 48,608 shares at a weighted average price of $41.41, with trades ranging from $41.137 to $42.135, and 1,392 shares at a weighted average price of $42.36, with trades ranging from $42.145 to $42.74. The reported transactions were effected pursuant to a Rule 10b5-1 plan adopted June 9, 2026.

What were the terms of Alex Haro's LIF option exercise?

On October 6, 2026, Alex Haro exercised a fully vested and exercisable option for 50,000 common shares at $2.53 per share. The derivative entry listed 145,565 shares following the transaction and an expiration date of July 16, 2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Haro Alex

(Last)(First)(Middle)
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310

(Street)
SAN MATEO CALIFORNIA 94403

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock10/06/2026M(1)50,000A$2.531,060,303(2)D
Common stock10/06/2026S(1)48,608D$41.41(3)1,011,695(2)D
Common stock10/06/2026S(1)1,392D$42.36(4)1,010,303(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$2.5310/06/2026M(1)50,000 (5)07/16/2028Common stock50,000$0145,565D
Explanation of Responses:
1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
2. Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.137 to $42.135, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.145 to $42.74, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4.
5. The stock option is fully vested and exercisable.
Remarks:
/s/ Jay Sood, as Attorney-in-Fact10/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading